Abiopharma

🔍 Kroeger Christopher A. (Executive)

Company: MapLight Therapeutics, Inc. (MPLT)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 23,145 shares of Voting Common Stock (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,269,600.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Voting Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 101,190.00 | Footnotes: F3
• Acquired 93,955 shares of Employee Stock Option (right to buy) at $11.245 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2036-08-16 | equity_swap_involved: 0 | shares_owned_after: 93,955.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
• F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
• F3: The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
• F4: 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.